• Model N analysis found 35% of U.S. adults delayed, stretched, or skipped prescriptions due to unclear costs.
• Survey showed 46% do not consistently know prescription prices before reaching the pharmacy; 58% took cost-containment actions due to uncertainty.
• Expected costs influenced treatment decisions for 46%, raising risk of non-initiation, substitution, or dose rationing that can pressure branded-drug demand.
• Price shopping increased: 72% checked prices using at least one method; 40% more likely to check than a year ago.
• Stakeholder opacity persists: 76% had never heard of PBMs or did not know their role, complicating formulary-driven access strategies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Model N Inc. published the original content used to generate this news brief on September 23, 2026, and is solely responsible for the information contained therein.